RATIONALE: Nicotine improves sensory processing in schizophrenic individuals, as measured by changes in auditory event-related potentials (ERPs). Nicotine administration also alters ERPs in mice by increasing the amplitude and gating of the P20 ERP component while decreasing the amplitude of the N40 ERP component. Less is known about the role of specific nicotinic acetylcholine receptor (nAChR) subtypes. OBJECTIVES: In this study, we examined whether nAChRs containing the beta2 subunit contribute to nicotine's effects on auditory ERPs. MATERIALS AND METHODS: We tested the effect of nicotine in wild-type mice and mice lacking the beta2 nAChR subunit. Mice underwent stereotaxic implantation of stainless steel electrodes located in the CA3 region of the hippocampus, and 50 paired click stimuli were delivered during each drug condition. RESULTS: There was no significant difference in P20 or N40 amplitude or gating between genotypes during the control condition, suggesting that beta2-containing receptors are not essential for the baseline auditory ERP response. Nicotine increased P20 amplitude and enhanced gating in wild-type and beta2 knockout mice, but only decreased N40 amplitude in wild-type mice. There was no effect of nicotine on N40 gating in either genotype. CONCLUSIONS: beta2-containing receptors are necessary for nicotine's effects on the N40 component of the mouse auditory ERP. These results suggest that beta2-containing nAChRs modulate sensory processing and may serve as a therapeutic target in schizophrenic individuals.
RATIONALE: Nicotine improves sensory processing in schizophrenic individuals, as measured by changes in auditory event-related potentials (ERPs). Nicotine administration also alters ERPs in mice by increasing the amplitude and gating of the P20 ERP component while decreasing the amplitude of the N40 ERP component. Less is known about the role of specific nicotinic acetylcholine receptor (nAChR) subtypes. OBJECTIVES: In this study, we examined whether nAChRs containing the beta2 subunit contribute to nicotine's effects on auditory ERPs. MATERIALS AND METHODS: We tested the effect of nicotine in wild-type mice and mice lacking the beta2nAChR subunit. Mice underwent stereotaxic implantation of stainless steel electrodes located in the CA3 region of the hippocampus, and 50 paired click stimuli were delivered during each drug condition. RESULTS: There was no significant difference in P20 or N40 amplitude or gating between genotypes during the control condition, suggesting that beta2-containing receptors are not essential for the baseline auditory ERP response. Nicotine increased P20 amplitude and enhanced gating in wild-type and beta2 knockout mice, but only decreased N40 amplitude in wild-type mice. There was no effect of nicotine on N40 gating in either genotype. CONCLUSIONS:beta2-containing receptors are necessary for nicotine's effects on the N40 component of the mouse auditory ERP. These results suggest that beta2-containing nAChRs modulate sensory processing and may serve as a therapeutic target in schizophrenic individuals.
Authors: Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman Journal: Arch Gen Psychiatry Date: 2002-12
Authors: Richard J Radek; Holly M Miner; Natalie A Bratcher; Michael W Decker; Murali Gopalakrishnan; Robert S Bitner Journal: Psychopharmacology (Berl) Date: 2006-05-06 Impact factor: 4.530
Authors: Jason R Tregellas; Deana B Davalos; Donald C Rojas; Merilyne C Waldo; Linzi Gibson; Korey Wylie; Yiping P Du; Robert Freedman Journal: Schizophr Res Date: 2007-03-02 Impact factor: 4.939
Authors: Christina R Maxwell; Yuling Liang; Bryanne D Weightman; Stephen J Kanes; Ted Abel; Raquel E Gur; Bruce I Turetsky; Warren B Bilker; Robert H Lenox; Steven J Siegel Journal: Neuropsychopharmacology Date: 2004-04 Impact factor: 7.853
Authors: Noam D Rudnick; Andrew A Strasser; Jennifer M Phillips; Christopher Jepson; Freda Patterson; Joseph M Frey; Bruce I Turetsky; Caryn Lerman; Steven J Siegel Journal: Nicotine Tob Res Date: 2010-04-15 Impact factor: 4.244
Authors: Robert E Featherstone; Valerie M Tatard-Leitman; Jimmy D Suh; Robert Lin; Irwin Lucki; Steven J Siegel Journal: Psychopharmacology (Berl) Date: 2013-02-08 Impact factor: 4.530
Authors: Robert E Featherstone; Jennifer M Phillips; Tony Thieu; Richard S Ehrlichman; Tobias B Halene; Steven C Leiser; Edward Christian; Edwin Johnson; Caryn Lerman; Steven J Siegel Journal: PLoS One Date: 2012-07-20 Impact factor: 3.240